# European Transplant Registry of Senior Renal Transplant Recipients on Advagraf

> **NCT02558452** · — · NOT_YET_RECRUITING · sponsor: **Klemens Budde** · enrollment: 1000 (estimated)

## Conditions studied

- Graft Failure
- Death
- Acute Rejection of Renal Transplant
- Infections
- Bone Disease
- Post Transplant Diabetes Mellitus
- Quality of Life
- HLA Antibody Production
- Cardiovascular Risk Factors
- Non-HLA Antibody Production

## Interventions

- **DRUG:** Tacrolimus once daily (Advagraf)

## Key facts

- **NCT ID:** NCT02558452
- **Lead sponsor:** Klemens Budde
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2016-12
- **Primary completion:** 2027-01
- **Final completion:** 2028-01
- **Target enrollment:** 1000 (ESTIMATED)
- **Last updated:** 2016-08-12

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02558452

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02558452, "European Transplant Registry of Senior Renal Transplant Recipients on Advagraf". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02558452. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*